Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huoxue Baoxin Pill is a Traditional Chinese Medicine (TCM) compound preparation primarily utilized for the treatment of coronary heart disease (CHD). It is specifically indicated for patients presenting with the TCM syndrome of 'qi deficiency and blood stasis.' The formulation is designed to invigorate qi, promote blood circulation, and resolve blood stasis, thereby improving myocardial ischemia and overall cardiac function. Clinical research, including proteomic studies conducted at the First Hospital of Tianjin University of TCM, has explored its therapeutic mechanisms and its relationship with specific syndrome characteristics in cardiovascular patients. As an in-hospital preparation, it represents a targeted approach to integrating traditional syndrome differentiation with modern clinical analysis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Huoxue Baoxin Pill.